A share price of Third Harmonic Bio Inc [THRD] is currently trading at $10.79, down -1.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The THRD shares have gain 4.86% over the last week, with a monthly amount drifted -7.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Third Harmonic Bio Inc [NASDAQ: THRD] stock has seen the most recent analyst activity on August 09, 2024, when Morgan Stanley upgraded its rating to a Overweight and also boosted its price target to $20 from $12. Previously, Stifel started tracking the stock with Buy rating on June 18, 2024, and set its price target to $23. On June 07, 2024, Raymond James initiated with a Outperform rating and assigned a price target of $18 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $3.60 on December 16, 2022. Morgan Stanley downgraded its rating to a Equal-Weight but $5 remained the price target by the analyst firm on December 15, 2022. Morgan Stanley started tracking with a Overweight rating for this stock on October 10, 2022, and assigned it a price target of $34. In a note dated October 10, 2022, Jefferies initiated an Buy rating and provided a target price of $30 on this stock.
Third Harmonic Bio Inc experienced fluctuations in its stock price throughout the past year between $8.07 and $16.94. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Third Harmonic Bio Inc [NASDAQ: THRD] shares were valued at $10.79 at the most recent close of the market. An investor can expect a potential return of 85.36% based on the average THRD price forecast.
Analyzing the THRD fundamentals
Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at -63.2%, Pretax Profit Margin comes in at -46.89%, and Net Profit Margin reading is -46.89%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.14 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.52 points at the first support level, and at 10.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.03, and for the 2nd resistance point, it is at 11.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Third Harmonic Bio Inc [NASDAQ:THRD] is 42.50. In addition, the Quick Ratio stands at 42.50 and the Cash Ratio stands at 41.91.
Transactions by insiders
Recent insider trading involved Conner Edward R., Chief Medical Officer, that happened on Nov 08 ’24 when 2117.0 shares were sold. See Explanation of Responses, BVF PARTNERS L P/IL completed a deal on Oct 29 ’24 to sell 1.0 million shares. Meanwhile, Chief Medical Officer Conner Edward R. sold 2673.0 shares on Oct 28 ’24.
